Lack of efficacy of interferon-alpha therapy in recurrent, advanced cervical cancer

scientific article published on 01 December 1995

Lack of efficacy of interferon-alpha therapy in recurrent, advanced cervical cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/JIR.1995.15.1011
P698PubMed publication ID8746781

P50authorRuth TachezyQ39066606
P2093author name stringS Wadler
R D Burk
D Neuberg
R Comis
G Goldberg
C D Runowicz
R Rameau
F McGill
J Edmonson
P2860cites workInhibition of Rev-Mediated HIV-1 Expression by an RNA Binding Protein Encoded by the Interferon-Inducible 9-27 GeneQ34305842
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectcervix uterine cancerQ160105
P304page(s)1011-1016
P577publication date1995-12-01
P1433published inJournal of Interferon and Cytokine ResearchQ15754749
P1476titleLack of efficacy of interferon-alpha therapy in recurrent, advanced cervical cancer
P478volume15

Reverse relations

cites work (P2860)
Q48035556A phase II trial of interleukin-12 in patients with advanced cervical cancer: clinical and immunologic correlates. Eastern Cooperative Oncology Group study E1E96.
Q39755485Alpha interferon augments cidofovir's antiviral and antiproliferative activities
Q84957007Defective dendritic cell generation from monocytes is a potential reason for poor therapeutic efficacy of interferon α2b (IFNα2b) in cervical cancer
Q36350299Monocytes to functional dendritic cells is often a bridge too far for cancer therapy

Search more.